SS-31 50mg

Description

SS-31 50mg, also known as elamipretide, is a mitochondria-targeting tetrapeptide studied for its interaction with the inner mitochondrial membrane.

SS-31 has drawn considerable research interest because of its affinity for cardiolipin, an important phospholipid involved in maintaining mitochondrial membrane structure and supporting normal electron-transport-chain function. Rather than acting like a conventional stimulant, SS-31 research focuses on mitochondrial structure, cellular energetics, oxidative stress, and the biological consequences of mitochondrial dysfunction. 

This has made SS-31 a useful research compound in areas involving muscle function, cellular aging, cardiovascular biology, mitochondrial disorders, and metabolic stress.

Common research areas: mitochondrial function, cardiolipin biology, cellular energy production, oxidative stress, mitochondrial membrane integrity, and age-related mitochondrial changes.

Product Strength: 50mg

There has been a major regulatory development here: in September 2025, the FDA granted accelerated approval to Forzinity (elamipretide) for Barth syndrome in patients weighing at least 30 kg. A generic SS-31 50mg research product should not be presented as Forzinity or as the FDA-approved finished pharmaceutical product.